Isoprenaline Hydrochloride Macure Pharma Uk (Isoprenaline Hydrochloride)

The drug acts as a non‑selective beta‑adrenergic agonist, stimulating β1 receptors in the heart to raise heart rate and contractility, and β2 receptors in the lungs to relax bronchial smooth muscle, thereby improving airflow.

The dosage of Isoprenaline Hydrochloride is individualized and determined by the prescribing clinician based on the patient’s condition, response, and clinical guidelines. Specific dosing regimens are not provided here.

Safety data for Isoprenaline Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike selective β2‑agonists such as albuterol, Isoprenaline Hydrochloride stimulates both β1 and β2 receptors, offering combined cardiac stimulation and bronchodilation. This broader activity can be advantageous in emergency settings but may increase the risk of cardiac side effects compared with more selective agents.

Store the product at controlled room temperature, typically below 25 °C. Keep it in the original packaging, protect it from moisture and direct light, and ensure the container is tightly sealed to maintain sterility.

Isoprenaline Hydrochloride is administered intravenously by a qualified healthcare professional. The infusion rate and concentration are adjusted according to the patient’s clinical response and monitoring parameters.

Serious risks include life‑threatening arrhythmias, myocardial ischemia, severe hypotension, and anaphylactic reactions. Immediate medical attention is required if any of these events occur during or after administration.

Patients with known hypersensitivity to the drug, uncontrolled hypertension, pheochromocytoma, or severe coronary artery disease should avoid Isoprenaline Hydrochloride. Contraindications must be evaluated by a healthcare professional before use.